Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the immunohistochemistry (ihc) market right now?

The size of the immunohistochemistry (IHC) market has significantly increased in the past few years. The market is projected to expand from $2.58 billion in 2024 to $2.78 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. The prior growth has been driven by factors such as clinical application, standardization within the industry, growth in cancer research, laboratory automation, and advancements in clinical diagnostics.

How fast Is the immunohistochemistry (ihc) market expected to grow, and what’s its future value?

The market for immunohistochemistry (IHC) is projected to experience significant expansion in the ensuing years, with predictions showing growth to $4.13 billion by 2029, propelled by a compound annual growth rate (CAGR) of 10.4%. The predicted growth in the coming years can be traced back to factors such as the entry of new market participants, an increase in drug development, incorporation of biomedical research, diagnostic utilization, and advent of automation and digitalization. Key trends to watch throughout this forecast period include the use of multiplex IHC methods, integration with digital pathology, improved antibody specificity, increased automation and standardization, and its application in biomarker discovery.

Get your immunohistochemistry (ihc) market report here!

https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

What are the leading drivers of growth in the immunohistochemistry (ihc) market?

The surge in chronic diseases, diseases that persist for three months or more and can typically be managed but not healed, is anticipated to drive the immunohistochemistry (IHC) market. The IHC method plays an essential role in diagnosing chronic diseases like cancer, cardiovascular diseases, among others, owing to its many benefits such as precision, sensitivity (used for identifying specific antigens), quick results etc. As a perfect example, statistics from the Centers for Disease Control and Prevention, an American national public health authority, show that roughly 37.3 million individuals or 11.3% of the US population are suffering from diabetes in 2022. Thus, the increasing occurrence of chronic illnesses is fuelling the expansion of the immunohistochemistry (IHC) market.

What are the key segments defining the immunohistochemistry (ihc) market?

The immunohistochemistry (IHC) market covered in this report is segmented –

1) By Product: Antibodies, Equipment, Reagents, Kits

2) By Applications: Diagnostics, Drug Testing, Other Applications

3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies

2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes

3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media

4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

Who are the key players steering the development of the immunohistochemistry (ihc) market?

Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.

What emerging trends are influencing the growth of the immunohistochemistry (ihc) market?

Leading businesses in the immunohistochemistry (IHC) market are prioritizing the enhancement of diagnostic precision using cutting-edge technologies and superior reagents. This is to improve tissue analysis effectiveness in a variety of clinical and research settings. The Neoflex multiomics mass spectrometry imaging (MSI) system, an advanced imaging module, promotes accurate tissue analysis, thus allowing researchers to shift from discovery to clinical applications using high-resolution mass spectrometry methodologies. This is particularly beneficial for spatial mapping of biomolecules in tissues. For example, in June 2024, Bruker Corporation, an American company that creates and produces scientific tools as well as analytical and diagnostic solutions, introduced their matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for tissue imaging based on mass spectrometry. The Neoflex multiomics mass spectrometry imaging (MSI) system enables the transformation from discovery imaging to clinical tissue study. It is equipped with Bruker’s 10-kHz smartbeam 3D laser, improved imaging detectors, and offers OME-TIFF file output support with SCiLS Scope software.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9267

Which regions are most influential in expanding the immunohistochemistry (ihc) market?

North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

Orphan Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: